Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M SCHWARTZ

Showing results (371-380 of 3,479) with videos related to

Pageof 348
Sort By:
European Journal of Biochemistry|June 9, 1972
Inhibition of the catabolism of deoxyribonucleosides in Escherichia coli after infection by T 4 phageA Munch-Petersen, M Schwartz
JAMA Internal Medicine|February 5, 2014
Promotion of "low T" and the role of testosterone clinical trials--replyLisa M Schwartz, Steven Woloshin
JAMA Internal Medicine|August 14, 2013
Low "T" as in "template": how to sell diseaseLisa M Schwartz, Steven Woloshin
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2013
The Drug Facts Box: Improving the communication of prescription drug informationLisa M Schwartz, Steven Woloshin
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 6, 2018
Is My Patient Too Blue? Who Can Benefit From Early Intervention After a Bidirectional Cavopulmonary Anastomosis?Georgia Brown, Steven M Schwartz
Journal of General Internal Medicine|November 7, 2012
Getting to better prescription drug informationSteven Woloshin, Lisa M Schwartz
Frontiers in Psychiatry|April 23, 2021
Why Psychotropic Drugs Don't Cure Mental Illness-But Should They?Iliyan Ivanov, Jeffrey M Schwartz
BMJ (Clinical Research Ed.)|October 13, 2007
Participation in mammography screeningLisa M Schwartz, Steven Woloshin
The Medical Clinics of North America|January 1, 1976
Immune responsiveness and hematologic malignancy in the elderlyG Fernandez, J M Schwartz
JAMA|December 19, 2013
Medical communication companies and continuing medical education: clouding the sunshine?Lisa M Schwartz, Steven Woloshin
Pageof 348

Showing results (371-380 of 3,479) with videos related to

Sort By:
Pageof 348
European Journal of Biochemistry|June 9, 1972
Inhibition of the catabolism of deoxyribonucleosides in Escherichia coli after infection by T 4 phageA Munch-Petersen, M Schwartz
JAMA Internal Medicine|February 5, 2014
Promotion of "low T" and the role of testosterone clinical trials--replyLisa M Schwartz, Steven Woloshin
JAMA Internal Medicine|August 14, 2013
Low "T" as in "template": how to sell diseaseLisa M Schwartz, Steven Woloshin
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2013
The Drug Facts Box: Improving the communication of prescription drug informationLisa M Schwartz, Steven Woloshin
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 6, 2018
Is My Patient Too Blue? Who Can Benefit From Early Intervention After a Bidirectional Cavopulmonary Anastomosis?Georgia Brown, Steven M Schwartz
Journal of General Internal Medicine|November 7, 2012
Getting to better prescription drug informationSteven Woloshin, Lisa M Schwartz
Frontiers in Psychiatry|April 23, 2021
Why Psychotropic Drugs Don't Cure Mental Illness-But Should They?Iliyan Ivanov, Jeffrey M Schwartz
BMJ (Clinical Research Ed.)|October 13, 2007
Participation in mammography screeningLisa M Schwartz, Steven Woloshin
The Medical Clinics of North America|January 1, 1976
Immune responsiveness and hematologic malignancy in the elderlyG Fernandez, J M Schwartz
JAMA|December 19, 2013
Medical communication companies and continuing medical education: clouding the sunshine?Lisa M Schwartz, Steven Woloshin
Pageof 348